CNS stimulants, CNS depressants, anticonvulsants, Neuromusc
Help!
|
|
||||
|---|---|---|---|---|---|
| Central Nervous System | Brain and spinal cord
🗑
|
||||
| Amphetamines | stimulate the release of neurotransmitters (norepinephrine and dopamine); Adderall controls ADHD; causes euphoria and alertness
🗑
|
||||
| Amphetamines (side effects and adverse effects) | restlessness, insomnia, tachycardia, HTN, heart palpitations, dry mouth, anorexia, weight loss, diarrhea, constipation, impotence
🗑
|
||||
| Methylphenidate (prototype; trade name, contraindications; pregnancy category) | amphetamine-like drug (CNS stimulant)
Trade Name: Ritalin/Ritalin SR
Pregnancy Category: C
Contraindications: hypersensitivity, hyper thyroidism, anxiety, history of seizures, motor tics, Tourette syndrome, glaucoma
NOT to be used in children under 6
🗑
|
||||
| Methylphenidate (prototype; Pharmacokinetics and pharmacodynamics) | Kinetics: Well absorbed from GI
Half life: 1-3 hours
Excretion: 40% unchanged in urine
Dynamics: PO: onset = .5-1 hr; peak = 1-3 hours; duration = 4-6 hr
🗑
|
||||
| Methylphenidate (prototype; Dosage; Drug-Lab-Food Interactions) | ADHD: PO, 5 mg before breakfast and lunch
Narcolepsy: PO, 10 mg, BID/TID before meals
Drug interactions: may increase effects of decongestants, antiHTN, barbiturates; alter insulin
Food: caffeine may increase effects
🗑
|
||||
| Methylphenidate (prototype; uses) | correct hyperactivity caused by ADHD, increase attention span, treat fatigue, and control narcolepsy
🗑
|
||||
| Anorexiants (definition, use, side effects) | appetite suppressants; treat obesity; rarely prescribed; Didrex, Dexedrine, Dospan; do NOT give to children younger than 12 y.o.; nervousness, restlessness, irritability, insomnia, heart palpitations, HTN
🗑
|
||||
| Analeptics (definition, use, side effects) | CNS stimulant; stimulate respiration; may contain caffeine; used to stimulate increased respirations in newborns; nervousness, restlessness, tremors, twitching, palpitations, insomnia, diuresis, GI irritation, tinnitus; t1/2 = 3.5 hours
🗑
|
||||
| Doxapram (Dopram) | CNS and respiratory stimulant used to treat respiratory depression caused by drug OD, pre- and postanesthetic resp depression, COPD; IV c onset of 20-40 minutes and peaks at 2 minutes; HTN, tachycardia, trembling, and convulsions
🗑
|
||||
| Migraine headaches | characterized by a unilateral throbbing HEAD pain c nausea, vomiting, photophobia; caused by inflammation and dilation of blood vessels in cranium; etiology unknown; classic = aura, common = no aura
🗑
|
||||
| Cluster headaches | characterized by a severe unilateral NONthrobbing pain located around EYE; NO aura, NO nausea, NO vomiting
🗑
|
||||
| Migraine treatment | analgesics, opioid analgesics, ergot alkaloids, selective serotonin (5-HT) receptor agonists; MILD - aspirin, acetaminophen or NSAIDs; Demerol or Stadol NS
🗑
|
||||
| Sumatriptan (prototype; drug class, contraindications, dosage) | 5-HT receptor agonist (antimigraine)
Trade: Imitrex
Pregnancy Category: C
Contraindications: hypersenstivity, coronary artery disease, HTN, obesity, diabetes mel., smoking
Dosage: SubQ, PO, intranasal
🗑
|
||||
| REM rebound | results in vivid dreams and nightmares; frequently occurs after taking a hypnotic for a prolonged period then abruptly stopping; it MAY occur after one hypnotic dosage
🗑
|
||||
| Barbiturates (definition, long, intermediate) | sedative-hypnotic;
long-acting = control of seizures in epilepsy (Phenobarbital and mephobarbital)
intermediate-acting = sleep sustainers for maintaining sleep (butabarbital AKA Butisol) - ASSESS VITALS
🗑
|
||||
| Barbiturates (short and ultrashort) | short-acting = induce sleep (secobarbital AKA Seconal, pentobarbital AKA Nembutal - ASSESS VITALS
ultrashort-acting = general anesthetic; thiopental sodium AKA Pentothal
🗑
|
||||
| Secobarbital sodium (prototype; drug class, contraindications, dose) | sedative-hypnotic: barbiturate
Trade: Seconal Sodium
Pregnancy Category: D
Contraindications: resp depression, severe hepatic disease, pregnancy, nephrosis, hypersensitivity
Dosage: Sed - PO, Hyp - PO at bedtime, preop - PO 1-2 hr before
🗑
|
||||
| Secobarbital sodium (prototype; Drug interactions, Pharmacokinetics/dynamics) | Drug interactions: decrease resp c alcohol, CNS depressants, MAOIs
Pharmacokinetics: PO - 90% from GI; t1/2 = 15-40 hr; urine excretion as metabolites
Pharmacodynamics: PO - onset = 15-30 min; Peak = .5-1 hr; duration = 3-4 hrs
🗑
|
||||
| Secobarbital sodium (prototype; use, side effects) | treats insomnia; used for sedation, preop medication
Side effects: lethargy, drowsiness, hangover, dizziness, paradoxical excitement in elderly
🗑
|
||||
| Sumatriptan (prototype; pharmacokinetics/dynamics, use) | Pharmacokinetics: rapid absorp following subQ; 10-20% protein bound; t1/2 = 2 hrs; excretion in urine and feces
Pharmacodynamics: onset quicker with subQ than PO peak 2-4 hrs c both; duration unknown
treat migraine and cluster headaches
🗑
|
||||
| Sumatriptan (prototype; side effects) | dizziness, fainting, tingling, numbness, warm sensation, drowsiness, muscle cramps, nausea, vomiting, diarrhea, abdom cramping
Adverse reactions: hypotension, HTN, heart block, angina, dysrhythmias, thromboembolism, seizures, CNS hemorrhage, stroke
🗑
|
||||
| Benzodiazepines (Xanax, Ativan, Restoril) | minor tranquilizer, antianxiety agent
increase the action of the inhibitory neurotransmitter gamma-amniobutyric acid (GABA) to the GABA receptors; neuron excitability is reduced
can suppress stage 4 of REM, not to be used longer than 3-4 wks
🗑
|
||||
| Nonbenzodiazepines | used for short-term treatment (less than 10 days) for insomnia
🗑
|
||||
| flumazenil (Romazicon) | benzodiazepine antagonist; reversal of sedative effects; management of benzo OD
🗑
|
||||
| Zolpidem tartrate (prototype; drug class, contraindications, dosage, interactions) | Sedative-hypnotic; non-benzodiazepine
Trade: Ambien
Pregnancy Category: B
Contraind: allergy, lactation
Dosage: PO - at bedtime
Interactions: drug - decrease CNS function with alcohol, CNS depress, anticonvuls, phenothiazines; food - decreases absorp
🗑
|
||||
| Zolpidem tartrate (prototype; pharmacokinetics/dynamics, uses) | pharmacokinetics: PO, 79-96% protein bound; t1/2 = 2-2.5 hrs; excreted in bile, urine, feces
pharmacodynamics: PO; onset = 7-27 min; peak = .5-2.3 hrs; duration = 6-8 hrs
uses: treat insomnia
🗑
|
||||
| Zolpidem tartrate (prototype; side effects and adverse reactions) | side effects: drowsiness, lethargy, hangover (residual sedation), irritability, dizziness, anxiety, nausea, vomiting, hypervitaminosis A, bulging fontanelles
Adverse: tolerance, psychologic or physical dependence
🗑
|
||||
| Methylphenidate (prototype; mode of action) | acts primarily on the reticular activating system and cerebral cortex
🗑
|
||||
| Sumatriptan (prototype; mode of action) | causes vasoconstriction of cranial carotid arteries to relieve migraine attacks
🗑
|
||||
| Secobarbital sodium (prototype; mode of action) | depression of the CNS, including the motor and sensory activities
🗑
|
||||
| Zolpidem tartrate (prototype; mode of action) | depression of CNS, neurotransmitter inhibition
🗑
|
||||
| Anesthetics (general) | depress CNS, alleviate pain, and cause LOC
4 stages: analgesia, excitement/delirium, surgical, medullary paralysis (ventilation NEEDED)
IV MED
🗑
|
||||
| Balanced anesthesia | a hypnotic given the night before, premed c narcotic analgeic or benzodiazepine + anticholinergic, short acting barb, inhaled gas, muscle relaxant
* minimizes CV problems, decreases amount of gen anesth. needed, decreases pain; QUICKER RECOVERY
🗑
|
||||
| Anesthetics (local) | block pain at the site where drug is administered; allows consciousness to be maintained
Ethers or amides(low allergy incid)
Synthetic cocaine = Novocain
Short - .5-1 hr duration
Mod - 1-3 hr
Long - 3-10 hr
🗑
|
||||
| Spinal anesthesia | requires local to be injected in the subarachnoid space at the 3rd or 4th lumbar space
headaches may result - leaking
hypotension - leaking
🗑
|
||||
| Blocks (nerve, spinal, epidural, caudal, saddle) | Nerve: prevents pain at nerve ending
Spinal: subarachnoid membrane (2nd layer)
Epidural: outer covering (dura mater)
Caudal: near sacrum
Saddle: lower end to block perineal area (childbirth)
🗑
|
||||
| Brain anoxia | lack of oxygen to brain
🗑
|
||||
| Grand mal (tonic-clonic) seizure | most common; tonic - skeletal muscles contract in a spasm lasting 3-5 seconds; clonic - dysrhythmic muscular contraction, or jerkiness of legs and arms lasting 2-4 minutes; GENERALIZED
🗑
|
||||
| Petit mal (absence) seizure | brief LOC lasting less than 10 sec; usually occurs in children; fewer than 3 spike waves on EEG; GENERALIZED
🗑
|
||||
| Psychomotor seizure | complex symptoms - automatisms (repetitive behaviors), behavioral changes, motor seizures; PARTIAL - COMPLEX
🗑
|
||||
| Motor seizure | Jacksonian Seizure; involves spontaneous movement that spreads, can develop into generalized seizure; PARTIAL - SIMPLE
🗑
|
||||
| Anticonvulsants | used for epileptic seizures; AKA Antiepileptic drugs (AEDs); suppress the abnormal electric impulses from the seizure focus to other cortical areas - prevents seizure but does not eliminate cause; CNS depressant
🗑
|
||||
| Phenytoin (prototype; drug class, contraindications, dose) | anticonvulsant, hydantoin
Trade: Dilantin
Preg Category: D
Contraindications: allergy, heart block, psychiatric disorders, pregnancy
Dosage: PO and IV (loading dose)
Theraputic range: 10-20 mcg/ml
Toxic: 30-50 mcg/ml
🗑
|
||||
| Phentoin (prototype; pharmacokinetics/dynamincs) | pharmacokinetics: PO - slow; IM - erratic; 85-95% protein bound; t1/2 = 6-45 hrs (22); excreted in urine (small), bile/feces (mod)
Pharmacodyamics: PO - onset = .5-2 hr, peak = 1.5-3 hr, duration = 6-12 hr; IM - onset = 1 min-1 hr
🗑
|
||||
| Phentoin (prototype; interactions) | Drug: decreased with folic acid, calcium, antacids
Decreases effects of: anticoag, oral contra, antihist, corticoster, dopamine
Food: decreased adsorption
🗑
|
||||
| Phentoin (prototype; uses; side effects and adverse effects) | prevent tonic-clonic (grand mal) and complex partial seizures (psychomotor)
Side fx: headache, diplopia, confus, dizzi, sluggishness, decreased coord, slurred spch, rash, anorexia, naus, vomit, red-brwn colored urine
Adverse: depress, gingival hyrplasia
🗑
|
||||
| Phentoin (prototype; mode of action) | reduces motor cortex activity by altering transport of ions
🗑
|
||||
| Status epilepticus | rapid succession of epileptic seizures; treated c phenobarbital, a long-acting barbiturate
🗑
|
||||
| Succinimides | used to treat absence or petit mal seizures; acts by decreasing calcium influx thru the t-type Ca channels
Ethosuximide (Zarontin)
🗑
|
||||
| Oxazolidones/Oxazolidinedione | treat petit mal seizures; Trimethadione was first drug developed; many severe side effects
🗑
|
||||
| Divalproex sodium (Depakote) | treatment of manic episodes in bipolar disorders
🗑
|
||||
| Benzodiazepines (as an anticonvulsant) | Klonopin, Valium, Ativan
🗑
|
||||
| Anticholinergics | reduce rigidity in Parkinsonism; inhibit the release of acetylcholine; contraindicated if pt has glaucoma
DRY YOU UP
🗑
|
||||
| Carbidopa-levodopa (prototype; drug class, contraindications, dosage) | antiparkinson: dopaminergic
Trade: Sinemet
Pregnancy Category: C
Contraindications: narrow-angle glaucoma, severe cardiac, renal or hepatic disease
Dosage: PO - ratio of 10 carb/100 levo; extended release - 5 carb/200 levo
🗑
|
||||
| Carbidopa-levodopa (prototype; interactions, use) | Drug: increase HTN crisis c MAOIs; decrease levodopa effect c anticholinergics
Lab: may increase BUN, AST, ALT, ALP, LDH
Food: avoid foods c vitamin B6
Use: treat parksinsonism; relieve tremors and rigidity
🗑
|
||||
| Carbodopa-levodopa (prototype; pharmacokinetics/dynamics) | Pharmacokinetics: PO - well absorbed; carbidopa 36% protein bound, levodopa is unknown; t1/2 = 1-2 hrs; excreted in urine as metabolites
Pharmacodynamics: PO - onset = 15 min; peak = 1-3 hrs; duration = 5-12 hrs
🗑
|
||||
| Carbodopa-levodopa (prototype; side effects, adverse effects) | Side effects: anorexia, naus, vomit, dysphagia, fatigue, dizzi, headache, dry mouth, bitter taste, twitching, blurred vision, insomnia
Adverse effects: involuntary movements, palpitations, ortho hypotension, urinary rtn, psychosis, severe depres, halluc
🗑
|
||||
| Carbidopa-levodopa (prototype; mode of action) | transmission of levodopa to brain cells for conversion to dopamine; carbidopa blocks the conversion of levodopa to dopamine in the peripheral nervous system
🗑
|
||||
| Dopamine agonists | stimulate the dopamine receptors
ex: Amantadine (high tolerance); can be used for drug induced parkinsonism
🗑
|
||||
| MAO-B inhibitor (-ILINE) | the enzyme monoamine oxidase-B (MAO-B) causes catabolism of dopamine; selegILINE inhibits MAO-B - prolongs action of levodopa
ex: RasagILINE (Azilect)
🗑
|
||||
| COMT inhibitors (-CAPONE) | enzyme catechol-O-methyltransferase (COMT) inactivates dopamine; when taken c levodopa - increase amount of levodopa concentration in the brain
🗑
|
||||
| Acetylcholinesterase inhibitors (AChE) | tacrine (Cognex); donepezil (Aricept); rivastigmine (Exelon); permits more acetylcholine in the neuron receptors; used for Alzheimer's disease
🗑
|
||||
| Tacrine (prototype; drug class, contraindications, dosage, interactions) | acetylcholinesterase inhibitor
Trade: Cognex
Contra: liver/renal diseases
Dosage: PO qid
Interactions: increse ALT, AST
🗑
|
||||
| Tacrine (prototype; pharmacokinectics/dynamics, use) | Pharmacokinetics: PO - food decreases absorb rate; 50% pro bnd; t1/2 = 3 hrs; excreted in urine
Pharmacodynamics: onset = .5 hr; peak = 2 hrs; duration = 24-36 hrs
Use: improves memory loss
🗑
|
||||
| Tacrine (prototype; side effects, mode of action) | Side effects: anorexia, nausea, vomit, diarrhea, dizzi, hdache, constip, rhinitis, depression
Mode of action: elevates acetylcholine concentration
🗑
|
||||
| Myasthenia gravis (MG) | lack of nerve impulses and muscle responses at the myoneural junction
Causes: fatigue and muscular weakness of the resp system, facial muscles and extremities
Etiology: inadequate secretion of ACh or loss of ACh
🗑
|
||||
| Multiple sclerosis (MS) | attacks myelin sheath of nerve fiberws, causing lesions (plaques)
🗑
|
||||
| Myasthenic crisis | severe generalized muscle weakness and may involve the muscles of respiration; stress or inadequate dosing of AChE inhibitors can trigger
🗑
|
||||
| Cholinergic crisis | overdoing AChE inhibitors
Symptoms: miosis (pupil constriction; abnormal), pallor, sweating, vertigo, excess salivation, naus, vomit, ab crmping,diarrhea, bradycardia, involun muscle twitching
🗑
|
||||
| AChE inhibitors for MG | neostigmate (Prostigmin): short-acting; t1/2 = .5-1 hr; PO q2-4hr
pyridostigmine bromide (Mestinon): intermed action; PO q3-6 hrs
ambenonium chloride (Mytelase): long-acting; only given if above don't work
🗑
|
||||
| Pyridostigmine bromide (prototype; drug class, contraindications, interactions) | cholinesterase inhibitor
Trade: Mestinon
Preg Category: C
Contra: GI and GU obstruction, severe renal disease
Interactions: decreased effect c atropine, muscle relaxants, antidysrhythmics, magnesium
🗑
|
||||
| Pyridostigmine bromide (prototype; dosage, use, mode of action) | PO, sustained-release PO, IM/IV, adults and children
Use: control and treat myasthenia gravis
Mode of action: transmission of neuromuscular impulses by preventing destruction of acetylcholine
🗑
|
||||
| Pyridostigmine bromide (prototype; pharmacokinetics/dynamics) | Pharmacokinetics: PO - poorly absorbed, Sustained-release - 50%; t1/2 = PO - 3.5-4 hrs, IV - 2 hrs; excreted in urine by liver
Pharmacodynamics: IV, IM, PO, PO - SR (quickest to slowest onset); PO SR has longest duration; all peaks are unknown
🗑
|
||||
| Pyridostigmine bromide (prototype; side effects and adverse reactions) | Side effects: naus, vomit, diarrhea, hdache, dizzi, ab cramps, excess saliva, sweating, rash, miosis
Adverse effects: hypotension, bradycardia, urticaria
🗑
|
||||
| Clients c MS should avoid.... | histamine blockers, idomethacin (an NSAID) and beta-blockers
🗑
|
||||
| Carisoprodol (prototype; drug class, contraindications, dosage, interactions) | Centrally acting muscle relaxants
Trade: Soma, Sopropol
Pregnancy category: C
Contraindications: severe liver or renal disease
Dosage: PO bedtime
Interactions: increase CNS depression c alcohol, narcotics, sedative-hypnotics, antihistamines, antidepr
🗑
|
||||
| Carisoprodol (prototype; pharmacokinetics/dynamics) | Pharmacokinetics: PO - absorbs well; t1/2 = 8 hrs; excreted in urine
Pharmacodynamics: PO, onset = 30 mins, Peak = 3-4 hrs, duration = 4-6 hrs
🗑
|
||||
| Carisoprodol (prototype; mode of action; side effects; adverse effects) | Mode of action: blocks interneuronal activity
Side effects: naus, vomit, dizziness, weakness, insomnia
Adverse reactions: asthmatic attack, tachycardia, hypotension, diplopia
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
jodybreeze2013
Popular Pharmacology sets